KUALA LUMPUR, May 7 (Xinhua) -- Malaysia is seeking to position itself as a trusted partner in global clinical research, Health Minister Dzulkefly Ahmad said on Thursday.
To realize this, the country must strengthen its research ecosystem and regional collaborations as Asia emerges as a growing hub for global clinical trials, he said in his remarks at the 5th Clinical Research Malaysia Conference 2026.
"Malaysia cannot merely be a recipient or candidate for external innovation. Instead, Malaysia must carve and shape its own unique footprint on the global map of medical discovery," he said.
Dzulkefly said clinical research is not only important for scientific advancement, but also serves as a bridge for patients to gain earlier access to innovative and potentially life-saving treatments.
"We view this not just as a medical necessity but as a moral imperative to ensure equitable access to health innovation," he said, adding that such efforts will also facilitate high-value job creation.
Dzulkefly also stressed the need to strengthen infrastructure, governance and research support systems to ensure Malaysia remains competitive in the global clinical trials industry. ■
